V.A.C. Veraflo
Device Negative Pressure Systems & Dressings
PDI 00849554001299
General payments
$5,004,731
Research payments
$526,460
Through program year 2025, $5,004,731 in general payments and $526,460 in research payments were reported against V.A.C. Veraflo (Negative Pressure Systems & Dressings).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $958,235 | 2,820 |
| 2025 | Research | $162,486 | 15 |
| 2024 | General | $1,242,982 | 2,890 |
| 2024 | Research | $78,770 | 3 |
| 2023 | General | $1,193,585 | 3,108 |
| 2023 | Research | $187,038 | 5 |
| 2022 | General | $1,126,369 | 1,941 |
| 2022 | Research | $5,000 | 1 |
| 2021 | General | $483,561 | 1,532 |
| 2021 | Research | $93,166 | 7 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 92 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
12,291 general · 31 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.